Dyslipidemias
1 competing product in clinical development for Dyslipidemias.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY3202328 + Placebo + Atorvastatin + Simvastatin | Eli Lilly | Phase 1 | Completed | 33 |
1 competing product in clinical development for Dyslipidemias.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY3202328 + Placebo + Atorvastatin + Simvastatin | Eli Lilly | Phase 1 | Completed | 33 |